Ross Ahmara G

Kwok Alex, Chaqour Brahim, Khan Reas S, Aravand Puya, Dine Kimberly, Ross Ahmara G et al.

This study found resveratrol and SIRT1 overexpression protected retinal ganglion cells and vision in mice with indirect traumatic optic neuropathy. This suggests resveratrol could be a therapy for human traumatic optic neuropathy.

O'Neill Nuala, Meng Miranda, Chaqour Brahim, Dine Kimberly, Sarabu Neha, Pham Jennifer C et al.

Researchers found that smaller NEFH and SNCG promoters equally drive neuroprotective gene delivery to retinal ganglion cells in a glaucoma mouse model, improving RGC survival and vision. This allows for packaging larger therapeutic genes.

Meng Miranda, Chaqour Brahim, O'Neill Nuala, Dine Kimberly, Sarabu Neha, Ying Gui-Shuang et al.

This study compared Brn3a and RBPMS markers for counting retinal ganglion cells (RGCs). Both detect RGC loss in aging and optic neuropathy, but Brn3a offers more consistent manual counts, aiding glaucoma research.

Reggie Sara N, Avery Robert A, Bavinger James C, Jivraj Imran, Alfaro Cesar, Pistilli Maxwell et al.

OCT-detected retinal/choroidal folds were studied to differentiate mild papilledema from pseudopapilledema. Folds were common in papilledema but rare in pseudopapilledema, suggesting their presence indicates true papilledema.

Khan Reas S, Ross Ahmara G, Aravand Puya, Dine Kimberly, Selzer Evan B, Shindler Kenneth S

Repetitive mild head impacts or one severe impact in mice cause progressive retinal ganglion cell and vision loss, offering a reproducible model to test TON treatments.